# HYDROCHLOROTHIAZIDE

NDC: 69315-155
Generic name: HYDROCHLOROTHIAZIDE
Labeler / Manufacturer: Leading Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20191101

FDA application: ANDA040702

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69315-155"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69315-155
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c868894-667e-4a51-906a-838d63e420ba